Review
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2674-2692
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2674
Figure 1
Figure 1 Bacterial gradient with predominant bacteria. MDR: Multidrug resistance.
Figure 2
Figure 2 Empirical antimicrobial approach of abdominal post-surgical infections. CPE: Carbapenem-resistant Enterobacterales; C/T: Ceftolozane/tazobactam; CZA: Ceftazidime/avibactam; DAP: Daptomycin; I-R: Imipenem-relebactam; LVX: Levofloxacin; LNZ: Linezolid; MDR: Multidrug-resistance; MRSA: Methicillin-resistant Staphylococcus aureus; MTZ: Metronidazole; MVB: Meropenem-vaborbactam; TZP: Piperacillin-tazobactam; VAN: Vancomycin; VRE: Vancomycin-resistant Enterococci.